KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Non-Current Deffered Revenue (2020 - 2025)

Sarepta Therapeutics (SRPT) has 9 years of Non-Current Deffered Revenue data on record, last reported at $325.0 million in Q1 2025.

  • For Q1 2025, Non-Current Deffered Revenue changed 0.0% year-over-year to $325.0 million; the TTM value through Mar 2025 reached $325.0 million, changed 0.0%, while the annual FY2024 figure was $325.0 million, 25.63% down from the prior year.
  • Non-Current Deffered Revenue reached $325.0 million in Q1 2025 per SRPT's latest filing, roughly flat from $325.0 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $641.5 million in Q1 2021 and bottomed at $325.0 million in Q1 2024.
  • Average Non-Current Deffered Revenue over 5 years is $472.0 million, with a median of $485.0 million recorded in 2022.
  • Peak YoY movement for Non-Current Deffered Revenue: plummeted 32.99% in 2024, then changed 0.0% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $574.2 million in 2021, then fell by 15.54% to $485.0 million in 2022, then fell by 9.9% to $437.0 million in 2023, then dropped by 25.63% to $325.0 million in 2024, then changed by 0.0% to $325.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $325.0 million in Q1 2025, $325.0 million in Q4 2024, and $325.0 million in Q3 2024.